SeptiCyte RAPID® By Immunexpress Receives Regulatory Clearance from Australian Therapeutic Goods Administration (TGA)

PR Newswire
January 17, 2024 — 06:00 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Australia Education European healthcare medicine Seattle social media sports technology Twitter University

Related News:

/C O R R E C T I O N — DFS/

May 4, 2024 — 00:05

Ecogensus Develops Novel New Sustainable Resource: Plastic Substitutes Derived from Mixed Household Wastes

May 3, 2024 — 09:15

CFGI Acquires Leading German CFO Advisory Firm PAS Financial Advisory AG

May 3, 2024 — 09:00

QANDA Named to TIME’s Inaugural List of the World’s Top EdTech Companies in 2024

May 3, 2024 — 07:27

The Brand Promise announces its debut with worldwide partnerships in Spring 2024

May 2, 2024 — 19:41

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

May 2, 2024 — 07:01

Keeper Security Forges Cybersecurity Partnership With Williams Racing

May 2, 2024 — 07:00

MGM China Reports 2024 First Quarter Results

May 2, 2024 — 06:16

Chinese president’s upcoming visit to bring new hope to Serbia’s development: Vucic

May 1, 2024 — 11:51